Immunome, Inc. (IMNM)
NCM · Common · CUSIP 45257U108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMNM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45257U108
Market Cap
Small Cap
IPO
10/2/2020 · $12.00/share
Business: Immunome, Inci s a clinical-stage targeted oncology company committed to developing first- and best-in-class targeted therapies designed to improve outcomes for cancer patients.

Company Contact

CEO
Clay B. Siegall
CFO
Max Rosett
Headquarters
18702 N. Creek Parkway, Suite 100, Bothell, WA 98011
Phone
425-939-7410
Investor Relations
Max Rosett · 425-939-7410 · investors@immunome.com
SEC EDGAR Filings
View filings »